Translation and Validation of Indonesian Version of Scleroderma Health Assessment Questionnaire

Irma Ruslina Defi, Jennie Jennie, Vitriana Vitriana, Farida Arisanti


Systemic sclerosis (SSc) or Scleroderma is a chronic autoimmune disease characterized by vasculopathy, fibrosis, and autoimmunity. Scleroderma Health Assessment Questionnare (SHAQ) is a measurement of SSc that is more specific than Health Assessment Questionnaire (HAQ) disability index(DI) to measure disability and function.The aim of this study was to translate SHAQ into Indonesian language and assess its validity and reability. The SHAQ was translated into Indonesian language and then back translated to ensure the meaning. The Indonesian version was then applied to the SSc outpatients. The validity of HAQ-DI and VAS scores was assessed using Pearson Product Moment Correlation and Cronbach’s alpha for the reability test of SSc HAQ score. To determine the convergent validity, comparisons were made between HAQ-DI, Scleroderma Visual Analog Scale (VAS), and Short Form 36 (SF 36). Eighteen females, ranging between 42 to 66 years old, were included in this study from Desember 2019 to February 2020. The results of the validity test in all variables of HAQ-DI and SSc-VAS were valid (r-count >0.361). Cronbach’s alpha for these variables were higher than the standardized items (r > 0.700), reflecting very good reability and acceptable. There was a statistically significant correlation between SSc HAQ score and HAQ-DI with most of SF-36 physical domains, except for general health.The Indonesian version of SHAQ demonstrates a good construct and discriminant validity as well as the reproducibility. Thus, it can be used for measuring disability in systemic sclerosis patients.


Translasi  dan Validasi  Scleroderma Health Assessment Questionnaire versi  Bahasa Indonesia

Sklerosis sistemik atau skleroderma merupakan penyakit autoimun kronik dengan vaskulopati, fibrosis dan autoimunitas. Scleroderma Health Assessment Questionnaire (SHAQ)menilai disabilitas dan fungsi pada pasien sklerosis sistemiklebih spesifik dibandingkan Health Assessment Questionnaire (HAQ) Disability Index (DI). Tujuan dari penelitian ini adalah menerjemahkan SHAQ ke dalam bahasa Indonesia dan menilai validitas serta relialibilitasnya. Scleroderma Health Assessment Questionnaire diterjemahkan ke dalam bahasa Indonesia dan kemudian dilakukan translasi balik lalu kuesioner diisi oleh pasien sklerosis sistemik rawat jalan. Tes validitas HAQ-DI dan Visual Analog Scale (VAS) dinilai menggunakan korelasi Pearson dan reliabilitas menggunakan Cronbach’s alpha. Perbandingan antara HAQ-DI, Scleroderma-VAS, dan Short Form 36 (SF 36) dilakukan untuk menilai validitas konvergen. Subjek terdiri dari 18 orang wanita yang berusia antara 42 sampai 66 tahun dari Desember 2019 sampai Februari 2020. Hasil validitas pada semua parameter HAQ-DI dan SSc-VAS ditemukan valid (r hitung>0,361). Terdapat reliabilitas yang baik dilihat dari nilai Cronbach’s alpha yang lebih tinggi dari nilai r tabel (r>0,700). Terdapat korelasi yang signifikan antara Skleroderma-HAQ dan HAQ-DI dengan domain SF-36 kecuali domain kesehatan umum. Simpulan, bahwa SHAQ versi Indonesia memiliki konstruk dan validitas diskriminan serta reproduktifitas yang baik sehingga dapat digunakan untuk menilai disabilitas pada pasien sklerosis sistemik.


SHAQ; Short Form 36; Systemic sclerosis; VAS

Full Text:



Varga J. Systemic Sclerosis (Scleroderma). In: Goldman L, Schafer A (eds.) Goldman-Cecil Medicine. 25th edition. Philadelphia: Elsevier; 2016. p 1777-85.

Park EH, Strand V, Oh YJ, Song YW, Lee EB. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther. 2019;21(1):61

Gargani L, Pignone A, Agoston G, Moreo A, Capati E, Badano LP, et al. Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study. Am Heart J. 2013; 165(2):200-7.

Peoples C, Medsger TA Jr, Lucas M, Rosario BL, Feghali-Bostwick CA. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord 2016;1(2):177-240

Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, et al. ESVM guidelines-the diagnosis and management of Raynaud's phenomenon. VASA 2017;46(6): 413-423.

Vincent, Dewi S, Gunadi WR. Correlation Between Serum Procollagen Type-1 N-Terminal Propeptide Level With Modified Rodnan Skin Score In Systemic Sclerosis Patients. Indonesian Journal of Rheumatology. 2017;9(20):8-12.

Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. Concurrent validity of the Health Assessment Questionnaire Disability Index in scleroderma. Arthritis Care Res 1995:8(3):189–93.

Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient – generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40(11):1984–91.

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310(20):2191-4

Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al.Classification Criteria for Systemic Sclerosis: an ACR-EULAR collaborative initiative. Arthitis and Rheumatism. 2013;65(11):2737-2747.

Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, et al. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol. 2005;24(1):3-10.

Revicki DA, Rentz AM, Luo MP, Wong RL. Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illnes Therapy-Fatigue subscale for patients with ankylosing spondylitis. Health Qual Life Outcomes 2011; 9:36

Laras N, Perwitasari DA, Khoirunnisa SM. Validity of short form 36 (SF-36) Indonesian version on rheumatoid arthritis patients. JKKI 2016;7(3):80-86

Mukaka MM. A guide to appropiate use of correlation coefficient in medical research. Malawi Med J. 2012;24(3): 69-71

Orlandi AC, Cardoso FP, Santos LM, Cruz Vda G, Jones A, Kyser C, et al. Translation and cross-cultural adaptation of the Scleroderma Health Assessment Questionnaire to Brazilian Portuguese. Sao Paulo Med J. 2014; 132(3):163-9.

Temiz KD, Karakas F, Tekeoglu S, Yazici A, Isik OO, Cefle A. Validation of Turkish version of the Scleroderma Health Assessment Questionnaire. Clin Rheumatol 2019;38(7):1917-23.

Arat S, Verschueren P, De Langhe E,Smith V, Vanthuyne M, Diya L, et al. The Association of Illness Perceptions with physical and Mental Health in Systemic Sclerosis Patients: an exploratory Study. Musculoskeletal Care. 2012;10(1):18-28.

Sierakowska, M., Doroszkiewicz, H., Sierakowska, Olesinska M, Agnieszka GJ, Brzosko M et al. Factors associated with quality of life in systemic sclerosis: a cross-sectional study. Qual Life Res. 2019;28:3347–3354.

Somani A, Kar SK, Parida JR. Depression in systemic sclerosis: review of the neuro-immunologic link and pharmacological management. Med J DY Patil Univ. 2016;9:294-299.

Thombs BD, van Lankveld W, Bassel M, Baron M, Buzza R, Haslam S, et al. Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda. Arthritis Care Res (Hoboken) 2010;62:1181-9.


Article Metrics

Abstract view : 1133 times
PDF - 673 times

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License


View My Stats